GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

Eli Lilly’s investigational drug, retatrutide, delivered an average 80-week weight loss of 70 pounds at the highest dose.

GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers ...

Some patients taking GLP-1 drugs to lose weight or manage Type 2 diabetes are discovering an emerging potential side effect ...

Researchers studied oral GLP-1 medications and a gut bacteria supplement aimed at helping patients maintain weight loss after ...

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose ...

An interview discussing recent research on the association between GLP-1 receptor agonist use and the risk of atrial fibrillation.

NSCLC showed the largest reduction in metastatic progression with GLP-1RAs versus gliptins (HR 0.50), with significant ...

Hims & Hers Health will begin selling generic GLP-1 drugs in Canada for 149 Canadian dollars ($108.41) a month. The telehealth company will sell a generic version of Novo Nordisk's Ozempic ...

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking ...

One in eight U.S. adults are currently on a GLP-1 weight loss medication as the drug continues to gain popularity.

Healthcare Investors (HQH) offers high-yield healthcare exposure, but a tight NAV discount and payout risks warrant ...